Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Rating Change Truist Securities analysts reiterated a Buy rating on Bristol-Myers Squibb Company (NYSE:BMY) on July 31, 2026. Market Context Bristol-Myers Squibb Company operates…
Read moreRating Change Wells Fargo analysts reiterated a Equal-Weight rating on Bristol-Myers Squibb Company (NYSE:BMY) on July 31, 2026. Market Context Bristol-Myers Squibb Company…
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Welltower Inc. (NYSE:WELL) on July 31, 2026. Market Context Welltower Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on KKR & Co. Inc. (NYSE:KKR) on July 31, 2026.
Read moreRating Change BTIG analysts reiterated a Buy rating on Stryker Corporation (NYSE:SYK) on July 31, 2026. Market Context Stryker Corporation operates in the Healthcare sector. The…
Read moreRating Change Truist Securities analysts reiterated a Hold rating on Stryker Corporation (NYSE:SYK) on July 31, 2026. Market Context Stryker Corporation operates in the Healthcare…
Read moreRating Change Rosenblatt analysts reiterated a Buy rating on Arm Holdings plc American Depositary Shares (NASDAQ:ARM) on July 31, 2026. Market Context Arm Holdings plc American…
Read moreRating Change Argus Research analysts downgraded Boston Scientific Corporation (NYSE:BSX) from Buy to Hold on July 31, 2026. Market Context Boston Scientific Corporation operates…
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Outperform rating on Mastercard Incorporated (NYSE:MA) on July 31, 2026. Market Context Mastercard Incorporated…
Read moreRating Change Barclays analysts reiterated a Overweight rating on Mastercard Incorporated (NYSE:MA) on July 31, 2026. Market Context Mastercard Incorporated operates in the…
Read moreRating Change Keybanc analysts reiterated a Overweight rating on Mastercard Incorporated (NYSE:MA) on July 31, 2026. Market Context Mastercard Incorporated operates in the…
Read moreRating Change Guggenheim analysts reiterated a Buy rating on Bristol-Myers Squibb Company PFD CONV 2 (OTC:BMYMP) on July 31, 2026. Market Context Bristol-Myers Squibb Company PFD…
Read moreRating Change Truist Securities analysts reiterated a Buy rating on Bristol-Myers Squibb Company PFD CONV 2 (OTC:BMYMP) on July 31, 2026. Market Context Bristol-Myers Squibb…
Read moreRating Change Wells Fargo analysts reiterated a Equal-Weight rating on Bristol-Myers Squibb Company PFD CONV 2 (OTC:BMYMP) on July 31, 2026. Market Context Bristol-Myers Squibb…
Read moreRating Change Barclays analysts reiterated a Overweight rating on Amazon.com, Inc. (NASDAQ:AMZN) on July 31, 2026. Market Context Amazon.com, Inc.
Read moreRating Change JP Morgan analysts reiterated a Overweight rating on Amazon.com, Inc. (NASDAQ:AMZN) on July 31, 2026. Market Context Amazon.com, Inc.
Read moreRating Change Rosenblatt analysts reiterated a Buy rating on Amazon.com, Inc. (NASDAQ:AMZN) on July 31, 2026. Market Context Amazon.com, Inc.
Read moreRating Change Keybanc analysts reiterated a Overweight rating on Amazon.com, Inc. (NASDAQ:AMZN) on July 31, 2026. Market Context Amazon.com, Inc.
Read moreRating Change Citizens analysts reiterated a Market Outperform rating on Amazon.com, Inc. (NASDAQ:AMZN) on July 31, 2026. Market Context Amazon.com, Inc.
Read moreRating Change Needham analysts reiterated a Buy rating on Amazon.com, Inc. (NASDAQ:AMZN) on July 31, 2026. Market Context Amazon.com, Inc.
Read more
